Sosei Heptares Enters Into Multi-target Research Collaboration and License Agreement With Genentech Read more
Exclusive interview with AstraZeneca ahead of upcoming Wearable Injectors & Connected Devices Read more
Dicerna Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of Primary Hyperoxaluria Type 1 (PH1) Read more
Teva Completes Facilities Purchase in Pennsylvania for North America Research & Development Campus Read more